These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27892465)

  • 1. Distinct role of IL-1β in instigating disease in Sharpin
    Gurung P; Sharma BR; Kanneganti TD
    Sci Rep; 2016 Nov; 6():36634. PubMed ID: 27892465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice.
    Sharma BR; Karki R; Lee E; Zhu Q; Gurung P; Kanneganti TD
    Cell Death Differ; 2019 Mar; 26(4):741-750. PubMed ID: 30038386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.
    Peuhu E; Salomaa SI; De Franceschi N; Potter CS; Sundberg JP; Pouwels J
    PLoS One; 2017; 12(10):e0186628. PubMed ID: 29040328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice.
    Douglas T; Champagne C; Morizot A; Lapointe JM; Saleh M
    J Immunol; 2015 Sep; 195(5):2365-73. PubMed ID: 26216893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling.
    Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP
    PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharpin Controls Osteogenic Differentiation of Mesenchymal Bone Marrow Cells.
    Jeschke A; Catala-Lehnen P; Sieber S; Bickert T; Schweizer M; Koehne T; Wintges K; Marshall RP; Mautner A; Duchstein L; Otto B; Horst AK; Amling M; Kreienkamp HJ; Schinke T
    J Immunol; 2015 Oct; 195(8):3675-84. PubMed ID: 26363054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sharpin is a key regulator of skeletal homeostasis in a TNF-dependent manner.
    McGowan HW; Schuijers JA; Grills BL; McDonald SJ; Rickard JA; Silke J; McDonald AC
    J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):454-63. PubMed ID: 25524971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.
    Ang RL; Chan M; Legarda D; Sundberg JP; Sun SC; Gillespie VL; Chun N; Heeger PS; Xiong H; Lira SA; Ting AT
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34887354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Involvement of the Npl4 Zinc Finger Domains of SHARPIN and HOIL-1L in Linear Ubiquitin Chain Assembly Complex-Mediated Cell Death Protection.
    Shimizu S; Fujita H; Sasaki Y; Tsuruyama T; Fukuda K; Iwai K
    Mol Cell Biol; 2016 May; 36(10):1569-83. PubMed ID: 26976635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.
    Renninger ML; Seymour RE; Whiteley LO; Sundberg JP; Hogenesch H
    Exp Dermatol; 2010 Mar; 19(3):252-8. PubMed ID: 19650867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: SHARPIN is required for optimal NLRP3 inflammasome activation.
    Gurung P; Lamkanfi M; Kanneganti TD
    J Immunol; 2015 Mar; 194(5):2064-7. PubMed ID: 25637014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear ubiquitination prevents inflammation and regulates immune signalling.
    Gerlach B; Cordier SM; Schmukle AC; Emmerich CH; Rieser E; Haas TL; Webb AI; Rickard JA; Anderton H; Wong WW; Nachbur U; Gangoda L; Warnken U; Purcell AW; Silke J; Walczak H
    Nature; 2011 Mar; 471(7340):591-6. PubMed ID: 21455173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
    Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
    J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.
    Liang Y; Sundberg JP
    J Dermatol Sci; 2011 Sep; 63(3):148-53. PubMed ID: 21620685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome.
    Rabeony H; Pohin M; Vasseur P; Petit-Paris I; Jégou JF; Favot L; Frouin E; Boutet MA; Blanchard F; Togbe D; Ryffel B; Bernard FX; Lecron JC; Morel F
    Eur J Immunol; 2015 Oct; 45(10):2847-57. PubMed ID: 26147228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis.
    Seymour RE; Hasham MG; Cox GA; Shultz LD; Hogenesch H; Roopenian DC; Sundberg JP
    Genes Immun; 2007 Jul; 8(5):416-21. PubMed ID: 17538631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12.
    HogenEsch H; Torregrosa SE; Boggess D; Sundberg BA; Carroll J; Sundberg JP
    Eur J Immunol; 2001 Mar; 31(3):734-42. PubMed ID: 11241277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis.
    Iwai K
    Cell Cycle; 2011 Sep; 10(18):3095-104. PubMed ID: 21900745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHARPIN controls the development of regulatory T cells.
    Redecke V; Chaturvedi V; Kuriakose J; Häcker H
    Immunology; 2016 Jun; 148(2):216-26. PubMed ID: 26931177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.
    Liang Y; Seymour RE; Sundberg JP
    J Invest Dermatol; 2011 Jan; 131(1):141-9. PubMed ID: 20811394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.